Identification of a μ opiate receptor signaling mechanism in human placenta

Case Reports and Clinical Practice Review

Volumn 16, Issue 11, 2010, Pages

  Mantione, Kirk J ^a   Angert, Robert M ^b   Cadet, Patrick ^a   Kream, Richard M ^a   Stefano, George B ^a  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

Endogenous morphine; Nitric oxide; Opiate receptors; Placenta; Preeclampsia

Indexed keywords

BETA ACTIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; MORPHINE; MU 1 OPIATE RECEPTOR; MU OPIATE RECEPTOR; MU4 OPIATE RECEPTOR; NALOXONE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; UNCLASSIFIED DRUG; ISOPROTEIN; NARCOTIC AGENT; NARCOTIC ANTAGONIST; NITRIC OXIDE SYNTHASE;

AMPEROMETRY; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; HORMONAL REGULATION; HUMAN; HUMAN TISSUE; IMMUNOREGULATION; PLACENTA; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR INTRINSIC ACTIVITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; CHEMISTRY; DRUG EFFECT; FEMALE; GENETICS; METABOLISM; PHYSIOLOGY; PREGNANCY; SECRETION;

FEMALE; HUMANS; MORPHINE; NALOXONE; NARCOTIC ANTAGONISTS; NARCOTICS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PLACENTA; PREGNANCY; PROTEIN ISOFORMS; RECEPTORS, OPIOID, MU; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 79951568816     PISSN: 15076164     EISSN: 16433742     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Kream RM, Stefano GB: Endogenous morphine and nitric oxide coupled regulation of mitochondrial processes. Med Sci Monit, 2009; 15(12): RA263-68
2. Stefano GB, Kream RM: Dopamine, Morphine, and Nitric Oxide: An Evolutionary Signaling Triad. CNS Neurosci Ther, 2010; 16(3): e124-37
3. Kream RM, Stefano GB: De novo biosynthesis of morphine in animal cells: An evidence-based model. Med Sci Moni, 2006; 12(12): RA207-19
4. Zhu W, Mantione KJ, Shen L et al: Tyrosine and tyramine increase endogenous ganglionic morphine and dopamine levels in vitro and in vivo: CYP2D6 and tyrosine hydroxylase modulation demonstrates a dopamine coupling. Med Sci Monit, 2005; 11(11): BR397-404
5. Zhu W, Cadet P, Baggerman G et al: Human white blood cells synthesize morphine: CYP2D6 modulation. Journal of Immunology, 2005; 175: 7357-62
6. Cadet P, Mantione KJ, Stefano GB: Molecular identification and functional expression of mu3, a novel alternatively spliced variant of the human mu opiate receptor gene. J Immunol, 2003; 170: 5118-23
7. Prevot V, Rialas C, Croix D et al: Morphine and anandamide coupling to nitric oxide stimulated GnRH and CRF release from rat median eminence: Neurovascular regulation. Brain Res, 1998; 790: 236-44
8. Cadet P, Mantione KJ, Zhu W et al: A functionally coupled mu3-like opiate receptor/nitric oxide regulatory pathway in human multi-lineage progenitor cells. J Immunol, 2007; 179: 5839-44
9. Kream RM, Sheehan M, Cadet P et al: Persistence of evolutionary memory: Primordial six-transmembrane helical domain mu opiate receptors selectively linked to endogenous morphine signaling. Med Sci Monit, 2007; 13(12): SC5-SC6
10. Fricchione G, Zhu W, Cadet P et al: Identification of endogenous morphine and a mu3-like opiate alkaloid receptor in human brain tissue taken from a patient with intractable complex partial epilepsy. Med Sci Monit, 2008; 14(6): CS45-49
11. Zhu W, Ma Y, Bell A et al: Presence of morphine in rat amygdala: Evidence for the mu3 opiate receptor subtype via nitric oxide release in limbic structures. Med Sci Monit, 2004; 10(12): BR433-39
12. Olsen P, Rasmussen M, Zhu W et al: Human gliomas contain morphine. Med Sci Monit, 2005; 11(5): MS18-21
13. Vassilacopoulou D, Sideris DC, Vassiliou AG, Fragoulis EG: Identification and characterization of a novel form of the human L-dopa decarboxylase mRNA. Neurochem Res, 2004; 29: 1817-23
14. Siaterli MZ, Vassilacopoulou D, Fragoulis EG: Cloning and expression of human placental L-Dopa decarboxylase. Neurochem Res, 2003; 28: 797-803
15. Kokkinou I, Nikolouzou E, Hatzimanolis A et al: Expression of enzymatically active L-DOPA decarboxylase in human peripheral leukocytes. Blood Cells Mol Dis, 2009; 42: 92-98
16. Kokkinou I, Fragoulis EG, Vassilacopoulou D: The U937 macrophage cell line expresses enzymatically active L-Dopa decarboxylase. J Neuroimmunol, 2009; 216: 51-58
17. Huh MM, Friedhoff AJ. Multiple molecular forms of catechol-O-methyltransferase. Evidence for two distinct forms, and their purification and physical characterization. J Biol Chem, 1979; 254: 299-308
18. Burba JV: Catechol O-methyltransferase activity in the human placenta and liver. Can J Physiol Pharmacol, 1979; 57: 213-16
19. Barnea ER, MacLusky NJ, DeCherney AH, Naftolin F: Catechol-o-methyl transferase activity in the human term placenta. Am J Perinatol, 1988; 5: 121-27
20. Mantione KJ, Cadet P, Zhu W et al: Endogenous morphine signaling via nitric oxide regulates the expression of CYP2D6 and COMT: autocrine/ paracrine feedback inhibition. Addict Biol, 2008; 13: 118-23
21. Ahmed MS, Abdelhamid EE, Turner D: Biochemical and pharmacological studies on the opiate receptors from human placenta. Life Sci, 1983; 33(Suppl.1): 207-10
22. Ahmed MS: Characterization of solubilized opiate receptors from human placenta. Membr Biochem, 1983; 5: 35-47
23. Mansson E, Bare LA, Yang D: Isolation of a human kappa opioid receptor cDNA from placenta. Biochem Biophys Res Commun, 1994; 202: 1431
24. Stefano GB, Goumon Y, Bilfinger TV et al: Basal nitric oxide limits immune, nervous and cardiovascular excitation: Human endothelia express a mu opiate receptor. Progress in Neurobiology, 2000; 60: 513-30
25. Javadi-Paydar M, Lesani A, Vakilipour R et al: Evaluation of the tocolytic effect of morphine in a mouse model of lipopolysaccharide-induced preterm delivery: the role of nitric oxide. Eur J Obstet Gynecol Reprod Biol, 2009; 147: 166-72
26. Goumon Y, Casares F, Pryor S et al: Ascaris suum, an intestinal parasite, produces morphine. J Immunol, 2000; 165: 339-43
27. Leung MK, Dissous C, Capron A et al: Schistosoma mansoni: The presence and potential use of opiate-like substances. Exp Parasit, 1995; 81: 208-15
28. Roy S, Balasubramanian S, Wang J et al: Morphine inhibits VEGF expression in myocardial ischemia. Surgery, 2003; 134: 336-44
29. Balasubramanian S, Ramakrishnan S, Charboneau R et al: Morphine sulfate inhibits hypoxia-induced vascular endothelial growth factor expression in endothelial cells and cardiac myocytes. J Mol Cell Cardiol, 2001; 33: 2179-87
30. Singleton PA, Lingen MW, Fekete MJ et al: Methylnaltrexone inhibits opiate and VEGF-induced angiogenesis: role of receptor transactivation. Microvasc Res, 2006; 72: 3-11
31. Chen C, Farooqui M, Gupta K: Morphine stimulates vascular endothelial growth factor-like signaling in mouse retinal endothelial cells. Curr Neurovasc Res, 2006; 3: 171-80
32. Kroll J, Waltenberger J: A novel function of VEGF receptor-2 (KDR): rapid release of nitric oxide in response to VEGF-A stimulation in endothelial cells. Biochem Biophys Res Commun, 1999; 265: 636-39
33. Kroll J, Waltenberger J: VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR). Biochem Biophys Res Commun, 1998; 252: 743-46
34. Cudmore M, Ahmad S, Al-Ani B et al: VEGF-E activates endothelial nitric oxide synthase to induce angiogenesis via cGMP and PKG-independent pathways. Biochem Biophys Res Commun, 2006; 345: 1275-82
35. Bahtiyar MO, Buhimschi C, Ravishankar V et al: Contrasting effects of chronic hypoxia and nitric oxide synthase inhibition on circulating angiogenic factors in a rat model of growth restriction. Am J Obstet Gynecol, 2007; 196: 72-76
36. Ahmed A, Cudmore MJ: Can the biology of VEGF and haem oxygenases help solve pre-eclampsia? Biochem Soc Trans, 2009; 37: 1237-42
37. Groten T, Gebhard N, Kreienberg R et al: Differential expression of VE-cadherin and VEGFR2 in placental syncytiotrophoblast during preeclampsia - New perspectives to explain the pathophysiology. Placenta, 2010; 31: 339-43
38. Mutter WP, Karumanchi SA: Molecular mechanisms of preeclampsia. Microvasc Res, 2008; 75: 1-8
39. Thadhani R, Mutter WP, Wolf M et al: First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia. J Clin Endocrinol Metab, 2004; 89: 770-75
40. Lam C, Lim KH, Karumanchi SA: Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia. Hypertension, 2005; 46: 1077-85
41. Burton GJ, Jauniaux E: Placental oxidative stress: from miscarriage to preeclampsia. J Soc Gynecol Investig, 2004; 11: 342-52
42. Burton GJ, Yung HW, Cindrova-Davies T, Charnock-Jones DS: Placental endoplasmic reticulum stress and oxidative stress in the pathophysiology of unexplained intrauterine growth restriction and early onset preeclampsia. Placenta, 2009; 30(Suppl.A): S43-48
43. Rambhia S, Mantione KJ, Stefano GB, Cadet P: Morphine modulation of the ubiquitin-proteasome complex is neuroprotective. Med Sci Monit, 2005; 11(11): BR386-96
44. Park SU, Johnson AG, Penzes-Yost C, Facchini PJ: Analysis of promoters from tyrosine/dihydroxyphenylalanine decarboxylase and berberine bridge enzyme genes involved in benzylisoquinoline alkaloid biosynthesis in opium poppy. Plant Mol Biol, 1999; 40: 121-31
45. De-Eknamkul W, Zenk MH: Enzymatic formation of (R)-reticuline from 1,2-dehydroreticuline in the opium poppy plant. Tetrahedron Letters, 1990; 31: 4855-58
46. Poeaknapo C, Schmidt J, Brandsch M et al: Endogenous formation of morphine in human cells. Proceedings of the National Academy of Sciences of the USA, 2004; 101: 14091-96
47. Epple A, Nibbio B, Spector S, Brinn JE: Endogenous Codeine: Autocrine regulator of catecholamine release from chromaffin cells. Life Sci, 1994; 54: 695-702
48. Syvanen AC, Tilgmann C, Rinne J, Ulmanen I: Genetic polymorphism of catechol-O-methyltransferase (COMT): correlation of genotype with individual variation of S-COMT activity and comparison of the allele frequencies in the normal population and parkinsonian patients in Finland. Pharmacogenetics, 1997; 7: 65-71
49. Kunugi H, Nanko S, Ueki A et al: High and low activity alleles of catechol- O-methyltransferase gene: ethnic difference and possible association with Parkinson's disease. Neurosci Lett, 1997; 221: 202-4
50. Stefano GB, Hartman A, Bilfinger TV et al: Presence of the mu3 opiate receptor in endothelial cells: Coupling to nitric oxide production and vasodilation. J Biol Chem, 1995; 270: 30290-93
51. Mantione K, Zhu W, Rialas C et al: Morphine-6-glucuronide stimulates nitric oxide release in mussel neural tissues: Evidence for a morphine-6-glucuronide opiate receptor subtype. Cellular & Molecular Life Sciences, 2002; 59: 570-74
52. Bilfinger TV: Role of morphine in blood pressure modulation: influence of nitric oxide. Acta Pharmacol Sinica, 1999; 20: 458-59
53. Takeda Y, Miyamori I, Yoneda T et al: Brain nitric oxide synthase messenger RNA in central mineralocorticoid hypertension. Hypertension, 1997; 30: 953-56
54. Szmedra L, Bacharach DW: Effect of music on perceived exertion, plasma lactate, norepinephrine and cardiovascular hemodynamics during treadmill running. Int J Sports Med, 1998; 19: 32-37
55. Pechanova O, Jendekova L, Vrankova S: Effect of chronic apocynin treatment on nitric oxide and reactive oxygen species production in borderline and spontaneous hypertension. Pharmacol Rep, 2009; 61: 116-22
56. Pechanova O, Simko F: The role of nitric oxide in the maintenance of vasoactive balance. Physiol Res, 2007; 56(Suppl.2): S7-16
57. Ignarro LJ, Lippton H, Edwards JC et al: Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther, 1981; 218: 739-49
58. Omawari N, Dewhurst M, Vo P et al: Deficient nitric oxide responsible for reduced nerve blood flow in diabetic rats: effects of L-NAME, L-arginine, sodium nitroprusside and evening primrose oil. Br J Pharmacol, 1996; 118: 186-90
59. Moncada S: Nitric oxide. Journal of Hypertension - Supplement, 1994; 12: S35-39
60. Annerbrink K, Westberg L, Nilsson S et al: Catechol O-methyltransferase val158-met polymorphism is associated with abdominal obesity and blood pressure in men. Metabolism, 2008; 57: 708-11
61. Kanasaki K, Palmsten K, Sugimoto H et al: Deficiency in catechol-Omethyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia. Nature, 2008; 453: 1117-21
62. Costas CE, Doss NW, Humayun SG et al: Intrathecal morphine and blood pressure in preeclampsia. NIDA Res Monogr, 1986; 75: 509-11
63. Lee SB, Wong AP, Kanasaki K et al: Preeclampsia: 2-methoxyestradiol induces cytotrophoblast invasion and vascular development specifically under hypoxic conditions. Am J Pathol, 2010; 176: 710-20
64. Gui Y, Zheng XL, Zheng J, Walsh MP: Inhibition of rat aortic smooth muscle contraction by 2-methoxyestradiol. Am J Physiol Heart Circ Physiol, 2008; 295: H1935-42